Acceleron Pharma Inc. (XLRN) is a biopharmaceutical company that develops and commercializes therapies for patients with serious and rare diseases. The company's research focuses on proteins that regulate the growth and differentiation of cells involved in hematopoiesis (the formation of blood cells)
Acceleron Pharma Inc. (XLRN) is a biopharmaceutical company that develops and commercializes therapies for patients with serious and rare diseases. The company's research focuses on proteins that regulate the growth and differentiation of cells involved in hematopoiesis (the formation of blood cells)